Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Management of infectious diseases can be done with speedy diagnosis, implementation of preventive, and treatment strategies, and strict adherence to the treatment plan. Infectious diseases are lethal and may lead to death if not managed properly and in time. However, rapid and early diagnosis is the key in efficient management of the infectious diseases. Late diagnosis of the diseases often makes it difficult for proper management of the disease and to keep it from spreading.
As the prevalence of infectious diseases is increasing, the need of effective diagnostic tests is also increasing. Centralized laboratory testing has been the gold standard for disease diagnosis. However, emerging economies such as Africa (West Africa), India, Brazil, and China have limited centralized laboratory facilities. In emerging economies point of care diagnostic would be useful due to unavailability of labs, infrastructure, and trained personnel.
Market Dynamics
Technological advancements to facilitate speedy diagnosis and extensive product portfolios of infectious disease diagnostics offered by manufacturer’s supports the growth of infectious disease diagnostics market. Manufacturers are indulged in providing novel diagnostic solutions for identifying infectious diseases.
For instance, Becton Dickinson and Company launched first automated phenotypic test, BD Phoenix CPO detect test, to detect and classify carbapenemase-producing organisms (CPO) in 2017. Development of innovative point-of-care diagnostics for infectious diseases, wide applications in remote locations, constant disease outbreaks, and government funding for product development and research is expected to fuel growth of the market.
Key features of the study:
This report provides in-depth analysis of infectious disease diagnostics market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global infectious disease diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key companies covered as a part of this study include Danaher Corporation, Abbott Laboratories, Becton, Dickinson, and Company, F. Hoffmann La-Roche Ltd., Trinity Biotech Plc, Cardinal Health, Inc., BioMérieux, Bio-Rad Laboratories, Inc., AccuBioTech Co., Ltd., and Acon Laboratories, Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the infectious disease diagnostics market
Detailed Segmentation:
Global Infectious Disease Diagnostics Market, By Product Type:
Kits & Reagents
Instruments
Global Infectious Disease Diagnostics Market, By Disease Type:
HIV
Hepatitis
Healthcare Associated Infections (HAIs)
Human Papillomavirus (HPV)
Tuberculosis (TB)
Influenza
Others
Global Infectious Disease Diagnostics Market, By Technology:
Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Others
Global Infectious Disease Diagnostics Market, By Test Location:
Laboratory Testing
Point-of-Care Testing
Global Infectious Disease Diagnostics Market, By End User:
Hospitals
Pathology/Diagnostic Laboratories
Research Institutes
Home-Care Settings
Others
Global Infectious Disease Diagnostics Market, By Geography:
North America
By Product:
Kits & Reagents
Instruments
By Disease Type:
HIV
Hepatitis
Healthcare Associated Infections (HAIs)
Human Papillomavirus (HPV)
Tuberculosis (TB)
Influenza
Others
By Technology:
Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Others
By Test Location
Laboratory Testing
Point-of-Care Testing
By End User:
Hospitals
Pathology/Diagnostic Laboratories
Research Institutes
Home-Care Settings
Others
By Country:
U.S.
Canada
Europe
By Product:
Kits & Reagents
Instruments
By Disease Type:
HIV
Hepatitis
Healthcare Associated Infections (HAIs)
Human Papillomavirus (HPV)
Tuberculosis (TB)
Influenza
Others
By Technology:
Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Others
By Test Location
Laboratory Testing
Point-of-Care Testing
By End User:
Hospitals
Pathology/Diagnostic Laboratories
Research Institutes
Home-Care Settings
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product:
Kits & Reagents
Instruments
By Disease Type:
HIV
Hepatitis
Healthcare Associated Infections (HAIs)
Human Papillomavirus (HPV)
Tuberculosis (TB)
Influenza
Others
By Technology:
Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Others
By Test Location
Laboratory Testing
Point-of-Care Testing
By End User:
Hospitals
Pathology/Diagnostic Laboratories
Research Institutes
Home-Care Settings
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product:
Kits & Reagents
Instruments
By Disease Type:
HIV
Hepatitis
Healthcare Associated Infections (HAIs)
Human Papillomavirus (HPV)
Tuberculosis (TB)
Influenza
Others
By Technology:
Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Others
By Test Location
Laboratory Testing
Point-of-Care Testing
By End User:
Hospitals
Pathology/Diagnostic Laboratories
Research Institutes
Home-Care Settings
Others
By Country:
Brazil
Mexico
Rest of Latin America
Middle East
By Product:
Kits & Reagents
Instruments
By Disease Type:
HIV
Hepatitis
Healthcare Associated Infections (HAIs)
Human Papillomavirus (HPV)
Tuberculosis (TB)
Influenza
Others
By Technology:
Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Others
By Test Location
Laboratory Testing
Point-of-Care Testing
By End User:
Hospitals
Pathology/Diagnostic Laboratories
Research Institutes
Home-Care Settings
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product:
Kits & Reagents
Instruments
By Disease Type:
HIV
Hepatitis
Healthcare Associated Infections (HAIs)
Human Papillomavirus (HPV)
Tuberculosis (TB)
Influenza
Others
By Technology:
Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Others
By Test Location
Laboratory Testing
Point-of-Care Testing
By End User:
Hospitals
Pathology/Diagnostic Laboratories
Research Institutes
Home-Care Settings
Others
By Country:
Central Africa
South Africa
North Africa
Company Profiles
Danaher Corporation*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Abbott Laboratories
Becton, Dickinson, and Company
Hoffmann La-Roche Ltd.
Trinity Biotech Plc
Cardinal Health, Inc.
BioMérieux
Bio-Rad Laboratories, Inc.
AccuBioTech Co., Ltd.
Acon Laboratories, Inc.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Product Type
o Market Snippet, By Disease Type
o Market Snippet, By Technology
o Market Snippet, By Test Location
o Market Snippet, By End User
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o PEST Analysis
o PORTER's Analysis
o Regulatory Scenario
4. Global Infectious Disease Diagnostics Market, By Product Type, 2016 - 2026 (US$ Mn)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Kits & Reagents
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Instruments
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
5. Global Infectious Disease Diagnostics Market, By Disease Type, 2016 - 2026 (US$ Mn)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2016 - 2026
o Segment Trends
o HIV
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Hepatitis
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Healthcare Associated Infections (HAIs)
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Human Papillomavirus (HPV)
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Tuberculosis (TB)
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Influenza
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
6. Global Infectious Disease Diagnostics Market, By Technology, 2016 - 2026 (US$ Mn)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2016 - 2026
o Segment Trends
o Immunodiagnostics
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Polymerase Chain Reaction (PCR)
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Next Generation Sequencing (NGS)
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
7. Global Infectious Disease Diagnostics Market, By Test Location, 2016 - 2026 (US$ Mn)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2016 - 2026
o Segment Trends
o Laboratory Testing
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Point of Care Testing
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
8. Global Infectious Disease Diagnostics Market, By End User, 2016 - 2026 (US$ Mn)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2016 - 2026
o Segment Trends
o Hospitals
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Pathology/Diagnostic Laboratories
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Research Institutes
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Home-Care Settings
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
9. Global Infectious Disease Diagnostics Market, By Region, 2016 - 2026 (US$ Mn)
o Introduction
o Market Share Analysis, By Region, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, For Regions, 2017-2026
o North America
o Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Technology, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Test Location, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
o U.S.
o Canada
o Europe
o Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Technology, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Test Location, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Technology, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Test Location, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of APAC
o Latin America
o Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Technology, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Test Location, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
o Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Technology, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Test Location, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
o Central Africa
o South Africa
o North Africa
o Middle East
o Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Technology, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Test Location, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
o GCC
o Israel
o Rest of Middle East
10. Competitive Landscape
o Company Profiles
o Danaher Corporation
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Abbott Laboratories
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Becton, Dickinson, and Company
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o F.Hoffmann La-Roche Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Trinity Biotech Plc
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Cardinal Health, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o BioMérieux
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Bio-Rad Laboratories, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o AccuBioTech Co., Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Acon Laboratories, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
11. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 44 market data tables and 50 figures on "Infectious Disease Diagnostics Market - Global forecast to 2026".
